Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Afatinib demonstrates significant improvements in PFS in the LUX-lung 3 phase III trial

Sep. 21, 2012

Bionor Pharma presents phase II results for HIV vaccine

Sep. 20, 2012

Urinary CCL18 assessed as a biomarker for Gaucher's disease

Sep. 20, 2012

Dompe presents new TRPM8 antagonists with potent activity in neuropathic pain models

Sep. 20, 2012

Researchers present results from taliglucerase alfa trials

Sep. 20, 2012

First-in-human results show safety and immunogenicity of a novel AIDS vaccine

Sep. 20, 2012

SBC-102 demonstrates safety and clinical activity in patients with LAL deficiency

Sep. 19, 2012

Shionogi presents first results for the novel antibacterial agent COT-303

Sep. 19, 2012

Researchers design the first inhibitors of neurotrypsin, a molecular target for sarcopenia

Sep. 19, 2012

MT-102 improves heart function in rat model of cancer cachexia

Sep. 19, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.